Humana INC Form 4 insider transactions

Humana's Chief Financial Officer, Susan M. Diamond, reported multiple transactions involving company stock, including the vesting of restricted stock units and the associated tax liability.

Humana's Chief Administrative Officer, Timothy S. Huval, reported the vesting of restricted stock units and the subsequent sale of shares to cover tax liabilities.

Humana's Chief Legal Officer, Joseph C. Ventura, reported multiple transactions involving company stock and derivative securities on December 15, 2024.

Humana director Gordon Smith received 765 restricted stock units as part of the annual Director Compensation Program.

Director David T. Feinberg reports acquisition of Humana stock units through director's fees and deferred elections.

Director Brad D. Smith reports acquisition of Humana Inc. restricted stock units related to director fees.

Director Kurt J. Hilzinger reports acquisition of Humana Inc. stock units through director's fees and dividend reinvestment.

Humana's Chief Corporate Affairs Officer, William Kevin Fleming, reports a transaction involving the disposition of 11 shares of Humana common stock and updates to derivative security holdings.

George Renaudin II, President of Medicare & Medicaid at Humana Inc., reports the acquisition and disposal of Humana common stock and derivative securities.

John-Paul W. Felter, SVP, Chief Accounting Officer & Controller of Humana Inc., reports the vesting and disposal of restricted stock units to cover tax liabilities.

Humana's Chief Financial Officer, Susan Diamond, reported transactions involving company stock, including the vesting of restricted stock units and related tax liability payments.

Director Kurt J. Hilzinger reports changes in Humana Inc. beneficial ownership due to acquisition of restricted stock units.

Director Brad D. Smith reports acquisition of additional Humana stock units through director fees and dividend reinvestment.

David T. Feinberg, a director at Humana Inc., increased his holdings through the acquisition of restricted stock units (RSUs) via deferred director fees and dividend reinvestments.

Humana's CEO, Bruce Broussard, filed a Form 4 detailing transactions involving company stock and derivative securities.

Director William J. McDonald reports changes in Humana Inc. beneficial ownership, including acquisitions of restricted stock units and shares held in a living trust.

Director Brad D. Smith reports acquiring additional Humana Inc. stock units through director fees and dividend reinvestment.

Director David T. Feinberg reports acquisition of Humana stock units through director fees and dividend reinvestment.

Director Kurt J. Hilzinger reports acquisition of Humana stock units through director fees and dividend reinvestments, deferred until resignation.

George Renaudin II, President of Medicare & Medicaid at Humana Inc., reports changes in his beneficial ownership of company stock and derivative securities.